This comprehensive work explores the various types of biomarkers, their significance in early cancer detection, prognostication, and evaluation of therapeutic responses. It covers cutting-edge research on circulating tumor cells, cell-free DNA, exosomes, and other biomarkers that can revolutionize cancer management. Additionally, it discusses the challenges, advancements, and future prospects of utilizing circulating biomarkers in personalized cancer care.
Table of Contents
Preface
Sheila Spada and Lorenzo Galluzzi
1. Circulating biomarkers for diagnosis and response to therapies in cancer patients
Nat�lia Marc�li Stefanes, Maria Eduarda Cunha-Silva, Lisandra de Oliveira Silva,
Laura Otto Walter, Maria Cl�udia Santos-Silva, and Manas Ranjan Gartia
2. Identification of circulating tumor DNA as a biomarker for diagnosis and response to therapies in cancer patients
Ronan W. Hsieh, Lynn K. Symonds, Jason Siu, and Stacey A. Cohen
3. Identification of cell-free circulating epigenomic biomarkers for early diagnosis and response to therapies in breast cancer patients
Pooja Ratre, Suresh Thareja, Pradyumna Kumar Mishra
4. Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer
Sabareeswaran Krishnan, Shruthi Kanthaje, Punchappady Devasya Rekha,
M. Mujeeburahiman, and Chandrahas Koumar Ratnacaram
5. Interleukin 10: Bridging the chasms in the immune landscape of multiple myeloma
Queenie Fernandes, Abdul W. Ansari, Karama Makni-Maalej, Maysaloun Merhi,
Said Dermime, Aamir Ahmad, and Shahab Uddin
6. Nectin-4: A promising prognostic marker and therapeutic target in cancer
Shilpa Kuttikrishnan, Kirti S. Prabhu, Ummu Habeeba, Zahwa Mariyam, Queenie Fernandes, Mohsin Maqbool, Omar M. Khan, Ajaz A. Bhat, and Shahab Uddi
